RIPK4 and lung adenocarcinoma: As stated above, RIPK4 expression is confirmed to be positively associated with favorable prognosis in tongue SCC, lung adenocarcinoma, and hepatocellular carcinoma (Wang et al., 2014; Kopparam et al., 2017; Li et al., 2021).